Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grand Flight Investment is a leading Chinese venture capital firm that serves as the investment arm of Far East Horizon, a major financial services group. The firm specializes in growth-stage investments across several high-impact sectors, with a primary focus on healthcare, life sciences, and advanced technology. Grand Flight leverages the industrial and financial resources of its parent company to provide strategic support and capital to innovative companies. Its healthcare portfolio includes a diverse range of enterprises involved in medical device manufacturing, molecular diagnostics, and biopharmaceutical development. The firm is particularly active in the Chinese market, supporting companies that demonstrate strong technological differentiation and commercial potential.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grand Flight Investment.